Autoantibodies against type I IFNs in patients with life-threatening COVID-19Paul Bastard, Stuart G. Tangye, Lindsey B. Rosen et al.|Science|2020Cited by 2.9k
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19Qian Zhang, Juan Li, Paul Bastard et al.|Science|2020Cited by 2.4k
Autoantibodies neutralizing type I IFNs are present in ~4% of uninfected individuals over 70 years old and account for ~20% of COVID-19 deathsPaul Bastard, Luisa Imberti, Pascal Morel et al.|Science Immunology|2021Cited by 638
The risk of COVID-19 death is much greater and age dependent with type I IFN autoantibodiesJérémy Manry, Luisa Imberti, Paul Bastard et al.|Proceedings of the National Academy of Sciences|2022Cited by 198
Autoantibodies against type I IFNs in patients with critical influenza pneumoniaQian Zhang, José Luis Barrera Franco, Andrés Pizzorno et al.|The Journal of Experimental Medicine|2022Cited by 133